Skip to content
Screener

Haemonetics HAE Gross Carrying Amount

Gross Carrying Amount at other companies

ICU Medical logo
ICU MedicalICUI
$1.28B+0.2%
Solventum logo
SolventumSOLV
$4.78B-5.7%
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
ITG
Integer HoldingsITGR

Other financials

Income statement

See full
Revenue$339.4M+5.6%
Gross profit$202.8M+5.5%
Operating income$57.5M+6.7%
Net income$33.0M-3.0%
EPS (diluted)$0.72+2.9%

Balance sheet

See full
Cash & equivalents$223.4M-23.7%
Total debt$1.2B-4.1%
Total equity$837.1M-5.1%
Total assets$2.4B-3.9%

Cash flow

See full
Operating cash flow$52.3M+201%
CapEx$7.9M+111%
Free cash flow$44.4M+226%

Valuation

See full
Market cap$4B+58.1%
Enterprise value$4.95B+43.0%
P/E26.6×-10.9×
P/S+1.1×

Profitability

See full
Gross margin59%+2.1pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin21.5%+7.5pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.4×0.0×
Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsGross.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:09 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000313143-26-000120
June 27, 2026Gross Carrying Amount / (Dollars in Thousands)Accumulated Amortization / (Dollars in Thousands)Net Carrying Amount / (Dollars in Thousands)Weighted Average Remaining Life (Years)
Customer contracts and related relationships129,60177,47552,12611.1
Capitalized software97,63683,74113,8953.1
Patents and other7,4224,7632,6595.3
Trade names14,6087,4287,18010.2
Total$803,296$374,828$428,468
Non-amortizable:
In-process software development$6,044
Total$6,044

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's gross carrying amount?
Haemonetics (HAE) reported gross carrying amount of $803.3M in Q2 2026.
How has Haemonetics's gross carrying amount changed year-over-year?
Haemonetics's gross carrying amount increased by 3.1% year-over-year, from $779.51M to $803.3M.
What is the long-term trend for Haemonetics's gross carrying amount?
Over 3 years (2023 to 2026), Haemonetics's gross carrying amount has grown at a 6.2% compound annual growth rate (CAGR), from $672.72M to $805.52M.
What does gross carrying amount mean?
Gross Carrying Amount

Ask your AI about Haemonetics's gross carrying amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude